We demonstrated that reduction in OPG expression was significantly associated with aggressive oncogenic behavior of higher histological grade, presence of nodal and hepatic metastases, occurrence of recurrent hepatic metastasis, advanced stage, and vascular invasion, and was an independent predictor for recurrent hepatic metastasis and an independent prognosticator for poor survival. Here, TNFRSF11B is linked to metastasis.